Profiel
Jeff T.
Hutchins worked as a Director of Monoclonal Antibody Development at Glaxo Wellcome, Inc. from 1991 to 2007.
He then worked as a Vice President of Preclinical Research at Avid Bioservices, Inc. from 2012 to 2016.
He also held the position of Vice President of Preclinical Development at Inhibitex LLC.
Later, he worked as the Chief Operating & Scientific Officer at Scorpius Holdings, Inc. from 2017 to 2020.
He also worked as a Senior Vice President at Pelican Therapeutics, Inc. Dr. Hutchins received his undergraduate degree from Oral Roberts University and his doctorate from The University of Texas Health Science Center at Houston.
Eerdere bekende functies van Jeff Hutchins
| Bedrijven | Functie | Einde |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Operationeel Directeur | 31-12-2020 |
| AVID BIOSERVICES, INC. | Corporate Officer/Principal | 01-12-2016 |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Corporate Officer/Principal | 01-01-2007 |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Corporate Officer/Principal | - |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Corporate Officer/Principal | - |
Opleiding van Jeff Hutchins
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Avid Bioservices, Inc.
Avid Bioservices, Inc. Pharmaceuticals: MajorHealth Technology Engages in the developing and manufacturing of biologics | Health Technology |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Health Technology |
Oral Roberts University
Oral Roberts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
The University of Texas Health Science Center at Houston
The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















